CD24 and neoplasm: To test whether CD24+MDSC-DCS derived from CRC patients' peripheral blood could inhibit Tregs polarization, CD4+T cells collected from the peripheral blood of tumor patients were preactivated by anti-CD3 and anti-CD28 and cocultured with human MDSC-DCSfor 7 days.